506 related articles for article (PubMed ID: 11025353)
1. Potential uses of intravenous proton pump inhibitors to control gastric acid secretion.
Metz DC
Digestion; 2000; 62(2-3):73-81. PubMed ID: 11025353
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of omeprazole, lansoprazole, pantoprazole, and rabeprazole in the treatment of acid-related diseases.
Welage LS; Berardi RR
J Am Pharm Assoc (Wash); 2000; 40(1):52-62; quiz 121-3. PubMed ID: 10665250
[TBL] [Abstract][Full Text] [Related]
3. Replacement of oral proton pump inhibitors with intravenous pantoprazole to effectively control gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.
Metz DC; Forsmark C; Lew EA; Starr JA; Soffer EF; Bochenek W; Pisegna JR
Am J Gastroenterol; 2001 Dec; 96(12):3274-80. PubMed ID: 11774936
[TBL] [Abstract][Full Text] [Related]
4. Pantoprazole: an update of its pharmacological properties and therapeutic use in the management of acid-related disorders.
Cheer SM; Prakash A; Faulds D; Lamb HM
Drugs; 2003; 63(1):101-33. PubMed ID: 12487624
[TBL] [Abstract][Full Text] [Related]
5. Effect of pantoprazole versus other proton pump inhibitors on 24-hour intragastric pH and basal acid output in Zollinger-Ellison syndrome.
Ramdani A; Mignon M; Samoyeau R
Gastroenterol Clin Biol; 2002 Apr; 26(4):355-9. PubMed ID: 12070410
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy and safety of intravenously administered pantoprazole in the treatment of gastrinoma].
Modlin IM
Recenti Prog Med; 2001; 92(7-8):456-61. PubMed ID: 11475787
[TBL] [Abstract][Full Text] [Related]
7. Pantoprazole versus omeprazole in the treatment of acute gastric ulcers.
Witzel L; Gütz H; Hüttemann W; Schepp W
Aliment Pharmacol Ther; 1995 Feb; 9(1):19-24. PubMed ID: 7766739
[TBL] [Abstract][Full Text] [Related]
8. Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.
Clissold SP; Campoli-Richards DM
Drugs; 1986 Jul; 32(1):15-47. PubMed ID: 3527658
[TBL] [Abstract][Full Text] [Related]
9. Intravenous proton-pump inhibitors versus H2-antagonists for treatment of GI bleeding.
Huggins RM; Scates AC; Latour JK
Ann Pharmacother; 2003 Mar; 37(3):433-7. PubMed ID: 12639176
[TBL] [Abstract][Full Text] [Related]
10. Intravenous pantoprazole: a new tool for acutely ill patients who require acid suppression.
Trépanier EF
Can J Gastroenterol; 2000 Nov; 14 Suppl D():11D-20D. PubMed ID: 11110607
[TBL] [Abstract][Full Text] [Related]
11. [Visual documentation of the stability of intravenous solutions of omeprazole (Losec) and pantoprazole (Pantoloc)].
Leitner A; Zöllner P
Wien Med Wochenschr; 2002; 152(21-22):568-73. PubMed ID: 12506681
[TBL] [Abstract][Full Text] [Related]
12. Protonix. First i.v. proton pump inhibitor approved.
Nursing; 2002 Feb; 32(2):18, 20. PubMed ID: 11924161
[No Abstract] [Full Text] [Related]
13. Thyroxine in goiter, H. pylori infection, and gastritis.
Dietrich JW; Boehm BO
N Engl J Med; 2006 Sep; 355(11):1177; author reply 1177. PubMed ID: 16971728
[No Abstract] [Full Text] [Related]
14. The basis of differentiation of PPIs.
Sachs G; Shin JM
Drugs Today (Barc); 2004 Mar; 40 Suppl A():9-14. PubMed ID: 15190382
[TBL] [Abstract][Full Text] [Related]
15. Proton pump inhibitors.
Grover JK; Vats V
Trop Gastroenterol; 1999; 20(1):16-28. PubMed ID: 10464444
[No Abstract] [Full Text] [Related]
16. Intravenous pantoprazole rapidly controls gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.
Lew EA; Pisegna JR; Starr JA; Soffer EF; Forsmark C; Modlin IM; Walsh JH; Beg M; Bochenek W; Metz DC
Gastroenterology; 2000 Apr; 118(4):696-704. PubMed ID: 10734021
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of pentagastrin-induced gastric acid secretion by intravenous pantoprazole: a dose-response study.
Pisegna JR; Martin P; McKeand W; Ohning G; Walsh JH; Paul J
Am J Gastroenterol; 1999 Oct; 94(10):2874-80. PubMed ID: 10520836
[TBL] [Abstract][Full Text] [Related]
18. Pantoprazole, Prout and the proton pump.
Playford RJ; Podas T; Modlin I
Hosp Med; 1999 Jul; 60(7):500-4. PubMed ID: 10605542
[TBL] [Abstract][Full Text] [Related]
19. Switching between intravenous and oral pantoprazole.
Pisegna JR
J Clin Gastroenterol; 2001 Jan; 32(1):27-32. PubMed ID: 11154164
[TBL] [Abstract][Full Text] [Related]
20. Are the orally administered proton pump inhibitors equivalent? A comparison of lansoprazole, omeprazole, pantoprazole, and rabeprazole.
Thomson AB
Curr Gastroenterol Rep; 2000 Dec; 2(6):482-93. PubMed ID: 11079051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
